Literature DB >> 25589213

Weight reduction and aortic stiffness in obese children and adolescents: a 1-year follow-up study.

K N Hvidt1, M H Olsen2, H Ibsen3, J-C Holm4.   

Abstract

Little is known about the effect of weight reduction on aortic stiffness and especially so in the young. The present study investigates whether weight reduction influences aortic stiffness in obese children and adolescents. Carotid-femoral pulse wave velocity (cfPWV) and augmentation index at heart rate 75 (AIx@HR75) were measured in 72 obese patients aged 10-18 years at baseline and after 1-year of lifestyle intervention (follow-up). We found that although the degree of obesity decreased (Δbody mass index z-score: -0.24±0.45, P<0.0001), cfPWV was higher at follow-up (ΔcfPWV: 0.27±0.47 m s(-1), P<0.0001), which was explained by the increase in age (β=0.12 ms(-1)  per year, 95% confidence interval (CI) 0.07-0.17, P<0.0001) and partly by changes in mean arterial pressure and heart rate. Changes in cfPWV were not related to changes in obesity measures. No significant change was found in AIx@HR75 (ΔAIx@HR75: 2.10±9.73%, P=0.072), but changes in AIx@HR75 were related to changes in abdominal fat (Δwaist/height ratio: β=50.3, 95% CI 6.7-94.0, P=0.02) and changes in total body fat percent by dual energy X-ray absorptiometry scan (Δtotal body fat (%): β=0.7, 95% CI 0.1-1.3, P=0.02) when adjusted for gender and relevant baseline confounders. In conclusion, no clear effect of weight reduction was found on aortic stiffness, although changes in AIx@HR75 were associated with changes in both abdominal fat and total body fat percent. The higher cfPWV at follow-up was related to the older age.

Entities:  

Mesh:

Year:  2015        PMID: 25589213     DOI: 10.1038/jhh.2014.127

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  34 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School Study.

Authors:  George S Stergiou; Nikolaos G Yiannes; Vayia C Rarra
Journal:  Blood Press Monit       Date:  2006-08       Impact factor: 1.444

3.  Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis.

Authors:  I B Wilkinson; S A Fuchs; I M Jansen; J C Spratt; G D Murray; J R Cockcroft; D J Webb
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

4.  Guidelines for the use of pulse wave analysis in adults and children.

Authors:  Lee Stoner; Danielle M Lambrick; James Faulkner; Joanne Young
Journal:  J Atheroscler Thromb       Date:  2013-01-25       Impact factor: 4.928

5.  Body fat is associated with reduced aortic stiffness until middle age.

Authors:  Ben Corden; Niall G Keenan; Antonio S M de Marvao; Timothy J W Dawes; Alain Decesare; Tamara Diamond; Giuliana Durighel; Alun D Hughes; Stuart A Cook; Declan P O'Regan
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

6.  Blood pressure and obesity exert independent influences on pulse wave velocity in youth.

Authors:  Empar Lurbe; Isabel Torro; Consuelo Garcia-Vicent; Julio Alvarez; José Antonio Fernández-Fornoso; Josep Redon
Journal:  Hypertension       Date:  2012-06-25       Impact factor: 10.190

7.  Vascular smooth muscle responsiveness to nitric oxide is reduced in healthy adults with increased adiposity.

Authors:  Demetra D Christou; Gary L Pierce; Ashley E Walker; Moon-Hyon Hwang; Jeung-Ki Yoo; Meredith Luttrell; Thomas H Meade; Mark English; Douglas R Seals
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-20       Impact factor: 4.733

8.  Reference values of aortic pulse wave velocity in a large healthy population aged between 3 and 18 years.

Authors:  Erzsébet Valéria Hidvégi; Miklós Illyés; Béla Benczúr; Renáta M Böcskei; László Rátgéber; Zsófia Lenkey; Ferenc T Molnár; Attila Cziráki
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

Review 9.  An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man.

Authors:  M Karamanoglu; M F O'Rourke; A P Avolio; R P Kelly
Journal:  Eur Heart J       Date:  1993-02       Impact factor: 29.983

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  5 in total

1.  Arterial stiffness in HIV-infected youth and associations with HIV-related variables.

Authors:  Allison Ross Eckard; Paolo Raggi; Joshua H Ruff; Mary Ann O'Riordan; Julia C Rosebush; Danielle Labbato; Julie E Daniels; Monika Uribe-Leitz; Christopher T Longenecker; Grace A McComsey
Journal:  Virulence       Date:  2017-03-21       Impact factor: 5.882

2.  Longitudinal evaluation of an mHealth overweight and obesity management tool.

Authors:  Ida Olivia Juhl Langkjær; Cilius Esmann Fonvig; Louise Aas Holm; Andreas Friis Pihl; Jens-Christian Holm
Journal:  Mhealth       Date:  2022-01-20

3.  DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report.

Authors:  Luciana Neves Cosenso-Martin; Luiz Tadeu Giollo-Junior; José Fernando Vilela-Martin
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Serum Periostin as a Potential Biomarker in Pediatric Patients with Primary Hypertension.

Authors:  Michał Szyszka; Piotr Skrzypczyk; Anna Stelmaszczyk-Emmel; Małgorzata Pańczyk-Tomaszewska
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241

5.  Positive correlation of the serum angiopoietin-like protein 3 levels with the aortic augmentation index in patients with coronary artery disease.

Authors:  Yu-Shan Fu; Ji-Hung Wang; Chung-Jen Lee; Bang-Gee Hsu
Journal:  Ther Clin Risk Manag       Date:  2018-02-05       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.